- Ongoing, recruitingTherapeutic confirmatory (Phase III)
H8H-MC-LAHW: A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients with Migraine - PIONEER-PEDS2
This study, called PIONEER-PEDS2, is looking at a new medicine called Lasmiditan for children and teenagers with migraine headaches. It wants to see how safe the medicine is and if it causes any side effects over a year, specifically for each migraine attack treated.
For: MigraineFrance · Germany · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
H8H-MC-LAHV: Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
This study called PIONEER-PEDS1 is looking at a new medicine called lasmiditan to help children and teenagers with migraine headaches. It compares different doses of lasmiditan with a dummy pill (placebo) to see how well it works to stop pain. This is a big final stage study.
For: MigraineNetherlands · Germany · Spain